Figure 3
Figure 3. Nucleotide metabolism is different in vascular and lymphatic endothelial cells. (A) Vascular human dermal microvascular endothelial cells (HDMEC) were incubated 45 minutes with 20μM [3H]AMP in the presence of 20μM APCP, 250μM ATP, and 100μM Ap5A (as indicated on lanes 2-5), separated by TLC and developed by autoradiography. In another experiment, vascular and lymphatic cells were incubated for 25 minutes with 20μM [3H]AMP (lanes 6, 7). Blanks (Bl) show the radiochemical purity of [3H]AMP (lanes 1, 8), and arrows indicate the positions of nucleotide and adenosine standards. (B) Activities of ATPase, ADPase, ecto-5′-nucleotidase (5′-NT), and adenylate kinase were determined in vascular and lymphatic endothelial cells by using saturating concentrations of 3H-labeled nucleotide (mean ± SEM; n = 5). *P < .05. (C) Expression of CD73 on podoplanin-positive (lymphatic, left) and -negative (blood vessel, right) endothelial cells analyzed by FACS.

Nucleotide metabolism is different in vascular and lymphatic endothelial cells. (A) Vascular human dermal microvascular endothelial cells (HDMEC) were incubated 45 minutes with 20μM [3H]AMP in the presence of 20μM APCP, 250μM ATP, and 100μM Ap5A (as indicated on lanes 2-5), separated by TLC and developed by autoradiography. In another experiment, vascular and lymphatic cells were incubated for 25 minutes with 20μM [3H]AMP (lanes 6, 7). Blanks (Bl) show the radiochemical purity of [3H]AMP (lanes 1, 8), and arrows indicate the positions of nucleotide and adenosine standards. (B) Activities of ATPase, ADPase, ecto-5′-nucleotidase (5-NT), and adenylate kinase were determined in vascular and lymphatic endothelial cells by using saturating concentrations of 3H-labeled nucleotide (mean ± SEM; n = 5). *P < .05. (C) Expression of CD73 on podoplanin-positive (lymphatic, left) and -negative (blood vessel, right) endothelial cells analyzed by FACS.

Close Modal

or Create an Account

Close Modal
Close Modal